I also came across this article this morning, which is incredibly biased against Kazia, painting a picture that data from a "failed late-phase brain cancer trial" has been manipulated to "manufacture a path to FDA [approval]".
"Kazia Therapeutics has found a way to try to salvage a win from a failed late-phase brain cancer trial. By removing part of the control arm"